• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    1.23 Up 0.10(8.85%) Mar 5, 3:59PM EST
    Add to Portfolio
    Prev Close:1.13
    Open:1.13
    Bid:1.11 x 500
    Ask:1.71 x 2700
    1y Target Est:9.00
    Beta:2.66
    Next Earnings Date:N/A
    Day's Range:1.12 - 1.28
    52wk Range:0.91 - 6.24
    Volume:411,377
    Avg Vol (3m):217,223
    Market Cap:25.99M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXIIUp 8.85%25.99M
    AGNDown 0.11%70.68B
    ALNYUp 4.04%9.34B
    MRNA 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):277.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.80
    Quarterly EPS Est (Dec-14) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback